834 filings
Page 34 of 42
CORRESP
5t5v9p1vxxszg28
11 Dec 06
Correspondence with SEC
12:00am
UPLOAD
0qs7e
7 Dec 06
Letter from SEC
12:00am
UPLOAD
3ife800qvf0d6
5 Dec 06
Letter from SEC
12:00am
8-K
biq4icdi
14 Nov 06
DOR BioPharma Reports Third Quarter Financial Results, Reviews Recent Achievements
12:00am
10QSB
ev2azm5u7u5pto9xk
14 Nov 06
Quarterly report (small business)
12:00am
8-K
h0p3153chsgfsed
2 Oct 06
DOR BioPharma Awarded Two Grants Totaling $5.3 Million to Advance Ricin Toxin and Botulinum Toxin Vaccine Programs
12:00am
8-K
lzo3pnwpqjyq
28 Sep 06
Departure of Directors or Principal Officers
12:00am
8-K
drevo q1575
22 Sep 06
Other Events
12:00am
UPLOAD
dskss8 rkyt
19 Sep 06
Letter from SEC
12:00am
CORRESP
4gvnd5wd03
8 Sep 06
Correspondence with SEC
12:00am
8-K
xtq fjlskkaexwc
30 Aug 06
Entry into a Material Definitive Agreement
12:00am
CORRESP
4ns46
18 Aug 06
Correspondence with SEC
12:00am
UPLOAD
648sbej
15 Aug 06
Letter from SEC
12:00am
10QSB
k8o6os0
14 Aug 06
Quarterly report (small business)
12:00am
8-K
p8qobr239csbk2333a
14 Aug 06
DOR BioPharma, Inc. Reports Second Quarter 2006 Financial Results
12:00am
25-NSE
istj2yn 7c0kj
6 Jul 06
Exchange delisting
12:00am
424B3
wr5q0yxomdq74 218
30 May 06
Prospectus supplement
12:00am
EFFECT
ed197s5
26 May 06
Notice of effectiveness
12:00am
SB-2/A
0wgjr3w igr
25 May 06
Registration of securities for small business issuer (amended)
12:00am